254 results on '"Farkas, Péter"'
Search Results
2. Combined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen
3. Változások a könnyűlánc-amyloidosis kezelésében – egy nagy budapesti centrum adatai.
4. Morphologic and molecular analysis of Richter syndrome in chronic lymphocytic leukaemia patients treated with ibrutinib or venetoclax
5. Cyclophosphamide treatment evoked side effect on skeletal muscle actin, monitored by DSC
6. Myeloma multiplexben szenvedő betegek túlélési eredményei a Semmelweis Egyetem Belgyógyászati és Hematológiai Klinikáján.
7. Semmelweis Egyetem Iron Board – Vaspótlás-konszenzusdokumentum.
8. Monitoring the side effects with DSC caused by cyclophosphamide treatment
9. Genetic diversity analysis of brown marmorated stink bug, Halyomorpha halys based on mitochondrial COI and COII haplotypes
10. ddRAD sequencing: an emerging technology added to the biosecurity toolbox for tracing the origin of brown marmorated stink bug, Halyomorpha halys (Hemiptera: Pentatomidae)
11. The Predictive Power of Bosniak 3 and 4 Cystic Renal Lesion Categorization Using Contrast‐Enhanced Ultrasound.
12. Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation
13. Hogyan változott az akut myeloid leukaemiás betegek túlélése a terápiás lehetőségek bővülésével az elmúlt 10 évben klinikánkon?
14. Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms
15. Real-world data on the efficacy and safety of daratumumab treatment in Hungarian relapsed/refractory multiple myeloma patients
16. Effectiveness of the Combination of Rituximab and Standard Chemotherapeutic Regimens in Previously Untreated Patients with Chronic Lymphocytic Leukaemia in Real-Life: Results from a Noninterventional Study (CILI Study)
17. Initial understory response to experimental silvicultural treatments in a temperate oak-dominated forest
18. POSTER: CML-536 Apparent Cure for Chronic Myeloid Leukemia (CML): Treatment-Free Remission at Academic Centers in Hungary
19. AML-588 Advancements in the Diagnosis of Acute Myeloid Leukemia Through the Application of Optical Genome Mapping
20. MM-570 Real-World Results With Daratumumab-Bortezomib-Dexamethasone (DVd) Protocol – Or Sometimes Less Might Be More
21. CML-536 Apparent Cure for Chronic Myeloid Leukemia (CML): Treatment-Free Remission at Academic Centers in Hungary
22. POSTER: AML-588 Advancements in the Diagnosis of Acute Myeloid Leukemia Through the Application of Optical Genome Mapping
23. PB1909: LOW-BURDEN TP53 MUTATIONS REPRESENT FREQUENT GENETIC EVENTS IN CLL WITH AN INCREASED RISK FOR TREATMENT INITIATION
24. Towards a unified fronthaul-backhaul data plane for 5G The 5G-Crosshaul project approach
25. Complement activation, inflammation and relative ADAMTS13 deficiency in secondary thrombotic microangiopathies
26. Low‐burden TP53 mutations represent frequent genetic events in CLL with an increased risk for treatment initiation.
27. New possibilities of application of DSC as a new clinical diagnostic method: A review
28. Structural and Mechanical Investigation of Class I Biomimetic Composite Dental Filling by X-ray Computed Tomography, Scanning Electron Microscopy, and Microtensile Bond Strength Testing
29. Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax
30. Additional value of microvascular flow imaging in the assessment of cystic and solid renal lesions
31. Demographic examination of Brown hare (Lepus europaeus) stocks with special reference during birth and survival in Eastern Hungary
32. Cyclophosphamide-induced changes in plasma and red blood cells detected by differential scanning calorimetry (DSC) in guinea pigs
33. Examination of the left ventricle damage in cyclophosphamide monotherapy with DSC in animal models
34. Examination of age distribution, time of birth and survival in a brown hare population
35. Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura
36. Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry
37. Examination of the peripheral nerve and muscle damage in cyclophosphamide monotherapy with DSC in animal models
38. Európai Sport: Fikció vagy Valóság?
39. Detection of Emerging Ibrutinib Resistance by Flow Cytometry in Patients with Chronic Lymphocytic Leukaemia
40. Cardiac Amyloidosis with Normal Wall Thickness: Prevalence, Clinical Characteristics and Outcome in a Retrospective Analysis
41. New 2D-MC-DS-SS-CDMA Techniques Based on Two-Dimensional Orthogonal Complete Complementary Codes
42. Die Prädialisten (kirchlichen Edlen) des Kapitels Wesprim im 14. Jahrhundert
43. Familial multiple myeloma. Two more families
44. EXPANSION OF HIGHER EDUCATION IN HUNGARY: CONSEQUENCES AND CONSTRAINTS
45. Detection of Emerging Ibrutinib Resistance by Flow Cytometry in Patients with Chronic Lymphocytic Leukemia
46. Examination of Glass-Fibre Reinforced Composite Dental Fillings
47. Ground motion map of Hungary
48. Concurrent Testing of Spatially Separated Tissue Samples and Circulating Tumor DNA Reveals Substantial Intra-Patient Genetic Heterogeneity in Relapsed/Refractory Follicular Lymphoma
49. Screening and monitoring of the BTKC481S mutation in a real‐world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy
50. Cyclophosphamide treatment evoked side effect on skeletal muscle actin, monitored by DSC
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.